Published by:
MIT Sloan School of Management
Length: 6 pages
Share a link:
https://casecent.re/p/130876
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
The only way to move forward on society's biggest challenges may be through consortiums. But it's not easy to assemble such groups or to keep them together. The experiences of The Biomarkers Consortium, a nine-year-old public-private partnership in the health industry, presents five lessons in managing these kinds of complex collaborations. These lessons are useful for anyone trying to build consensus to address broad societal challenges among multiple stakeholders with both common and divergent interests.
About
Abstract
The only way to move forward on society's biggest challenges may be through consortiums. But it's not easy to assemble such groups or to keep them together. The experiences of The Biomarkers Consortium, a nine-year-old public-private partnership in the health industry, presents five lessons in managing these kinds of complex collaborations. These lessons are useful for anyone trying to build consensus to address broad societal challenges among multiple stakeholders with both common and divergent interests.